| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |